|1.||Turski, Waldemar A: 3 articles (06/2014 - 07/2009)|
|2.||Kiś, Jacek: 3 articles (06/2014 - 07/2009)|
|3.||Czuczwar, Mirosław: 3 articles (06/2014 - 07/2009)|
|4.||Rejdak, Konrad: 2 articles (06/2014 - 04/2011)|
|5.||Wlaź, Piotr: 2 articles (06/2014 - 04/2011)|
|6.||Nieoczym, Dorota: 2 articles (06/2014 - 04/2011)|
|7.||Itahashi, Megu: 2 articles (01/2013 - 01/2013)|
|8.||Akane, Hirotoshi: 2 articles (01/2013 - 01/2013)|
|9.||Suzuki, Kazuhiko: 2 articles (01/2013 - 01/2013)|
|10.||Morita, Reiko: 2 articles (01/2013 - 01/2013)|
01/01/2004 - "The present investigation aimed to elucidate the analgesic efficacy of 30 mg of intravenous orphenadrine citrate (CAS 4682-36-4) in a human pain model. "
01/01/2004 - "This technique allowed studying the influence of orphenadrine citrate on the (central) P2-component and the (peripheral) Ni-component of the pain response (LSEP). "
01/01/2003 - "The pain curve under mefenamine acid showed a significant increase during the first 48 hours after extraction. "
01/01/1979 - "Analgesic combinations with orphenadrine in oral post-surgical pain."
07/01/1964 - "ORPHENADRINE CITRATE IN THE TREATMENT OF MUSCULAR PAIN."
01/10/1998 - "There are numerous reports of deaths following orphenadrine overdoses. "
03/01/1983 - "the present results show that although physostigmine may be helpful in the treatment of central anticholinergic effects caused by overdoses of orphenadrine and imipramine it is of no use for combating the direct toxic effects of both drugs on the cardiovascular system."
03/01/1982 - "The influence of physostigmine on respiratory and circulatory changes caused by overdoses of orphenadrine or imipramine in the rat."
03/01/1982 - "Although physostigmine may be useful in the treatment of the anticholinergic syndrome it has, at least in the rat, no favourable effect on the respiratory insufficiency, due to overdoses of orphenadrine and imipramine. "
|3.||Schizophrenia (Dementia Praecox)
03/01/1961 - "[Further contributions to study of the therapeutic effects of combined reserpine and orphenadrine in massive doses in chronic schizophrenia]."
06/01/1993 - "Effects of placebo, orphenadrine, and rising doses of chlorpromazine, on PAT performance in chronic schizophrenia. "
01/01/1986 - "Combination therapy with haloperidol and orphenadrine in schizophrenia. "
01/01/1961 - "[On the treatment of asymptomatic schizophrenia with very high doses of reserpine and orphenadrine]."
01/01/2000 - "To determine whether the use or the withdrawal of anticholinergic drugs (benzhexol or benztropine or biperiden or orphenadrine or procyclidine or scopolamine or trihexylphenidyl) were clinically effective for the treatment of people with both neuroleptic-induced TD and schizophrenia or other chronic mental illnesses. "
12/23/2000 - "An 11-year-old girl had a one-day history of nausea and vomiting for which her family physician prescribed 4 suppositories of prochlorperazine 25 mg. Five hours after the last dose she developed dystonic posturing; she recovered rapidly after intramuscular injection of 40 mg orphenadrine."
03/01/1997 - "The efficacy and tolerability of granisetron in the management of acute and delayed emesis was compared with that of a multiple antiemetic drug combination regimen, including metoclopramide, dexamethasone, lorazepam and orphenadrine. "
12/01/1994 - "The antiemetic efficacy of ondansetron and dexamethasone (Ondex) was randomly compared to that of high-dose metoclopramide, dexamethasone, and orphenadrine (Control) in the prevention of emesis induced by cyclophosphamide-doxorubicin chemotherapy in 64 chemotherapy-naive breast cancer patients. "
|5.||Restless Legs Syndrome (Restless Legs)
|1.||Diclofenac (SR 38)
|2.||Drug Therapy (Chemotherapy)
|3.||Musculoskeletal Manipulations (Manipulative Therapy)